REGULUS

REGULUS is a clinical biopharmaceutical company focused on the discovery and development of innovative drugs targeting microRNAs. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but rather regulate gene expression. The Regulus team is dedicated to the discovery and development of microRNA therapies, as dysregulation of microRNA expression is a key factor in many complex multifactorial diseases, including inflammatory diseases, fibrosis, metabolic disorders, and cancer. MicroRNA therapy utilizes oligonucleotides to modulate the function of microRNAs, correcting imbalances in gene expression and associated cellular pathways to treat a variety of human diseases.